Clinical Trial

PET/CT for Trop2 ADC Response Evaluation Cancers

Name: PET/CT for Trop2 ADC Response Evaluation Cancers — clinical trial record (NCT07046689)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate whether serial 68Ga-MY6349 PET/CT imaging can serve as a noninvasive biomarker to predict the therapeutic efficacy of Trop2-targeted antibody-drug conjugate (Trop2-ADC) therapy in breast cancer patients.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-06-23.

Trial Details

NCT Number	NCT07046689
Lead Sponsor	The First Affiliated Hospital of Xiamen University
Conditions	Breast Cancer, Trop2, PET/CT
Enrollment	50 participants
Start Date	2024-11-01
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-07-15